🇺🇸 FDA
Company

HALOZYME

HALOZYME THERAPEUTICS, INC.

HALO biotech USA

Quick answer

HALOZYME is a biotech company (HALO) headquartered in SAN DIEGO, CA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

Hylenex

Pain

Phase 3 · small_molecule · completed

1 trials project

Placebo

Pancreatic Ductal Carcinoma

Phase 3 · small_molecule · terminated

1 trials project

Testosterone enanthate

Hypogonadism, Male

Phase 3 · other · active

1 trials project

5-Fluorouracil (5-FU)

Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma

Phase 2 · small_molecule · completed

1 trials project

Atezolizumab

Pancreatic Ductal Adenocarcinoma

Phase 2 · small_molecule · terminated

1 trials project

Axumin PET/CT

Prostate Cancer

Phase 2 · small_molecule · completed

1 trials project

CINRYZE with rHuPH20

Hereditary Angioedema

Phase 2 · mab · completed

1 trials project

Eribulin mesylate

Metastatic Breast Cancer

Phase 2 · small_molecule · terminated

1 trials project

Gemcitabine

Stage IV Pancreatic Cancer

Phase 2 · small_molecule · completed

1 trials project

Humalog

Type 1 Diabetes Mellitus

Phase 2 · small_molecule · completed

1 trials project

Humalog

Diabetes Mellitus, Type 2

Phase 2 · small_molecule · completed

1 trials project

Insulin lispro

Diabetes Mellitus, Type II

Phase 2 · small_molecule · completed

1 trials project

Insulin lispro

Diabetes Mellitus, Type 1

Phase 2 · small_molecule · completed

2 trials project

Mitomycin C

Bladder Cancer

Phase 2 · small_molecule · completed

1 trials project

PEGPH20

Metastatic Pancreatic Cancer

Phase 2 · small_molecule · completed

1 trials project

PEGPH20

Pancreatic Ductal Adenocarcinoma

Phase 2 · small_molecule · active

1 trials project

PEGPH20

Metastatic Pancreatic Adenocarcinoma

Phase 2 · small_molecule · completed

1 trials project

Pegvorhyaluronidase alfa

Pancreatic Ductal Adenocarcinoma

Phase 2 · small_molecule · terminated

1 trials project

rHuPH20

Dermatitis, Allergic Contact

Phase 2 · small_molecule · completed

1 trials project

Chemophase

Superficial Bladder Cancer

Phase 1 · small_molecule · completed

1 trials project

Cohort 1: bococizumab 150 mg + rHuPH20

Healthy

Phase 1 · mab · terminated

1 trials project

Humalog

Diabetes Mellitus

Phase 1 · small_molecule · completed

1 trials project

Insulin Lispro

Diabetes Mellitus

Phase 1 · small_molecule · completed

1 trials project

Insulin aspart

Type 1 Diabetes Mellitus

Phase 1 · small_molecule · completed

1 trials

Drugs (1)

drug

hyaluronidase recombinant human

HYLENEX RECOMBINANT

Patents (8)

patent

US 12421308

Anti-G-CSF antibodies and uses thereof

Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12371685

PH20 polypeptide variants with a modification at position 324 of the PH20 polype

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12264345

PH20 polypeptide variants, formulations and uses thereof

Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12195773

PH20 polypeptide variants, formulations and uses thereof

Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12178860

Hyaluronidase enzyme formulations for high volume administration

Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12152262

PH20 polypeptide variants, formulations and uses thereof

Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12123035

PH20 polypeptide variants, formulations and uses thereof

Expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12110520

PH20 polypeptide variants, formulations and uses thereof

Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)